Antibodies recognizing tau
An antibody, humanized antibody technology, applied in the direction of antibodies, medical preparations with inactive ingredients, anti-animal/human immunoglobulin, etc., can solve problems such as interference with microtubule assembly, neuronal network damage, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0363] Example 1. Identification of tau monoclonal antibody
[0364] Monoclonal antibodies against tau were generated as follows. Recombinant 383a.a. human tau (4RON) with an N-terminal His tag containing the P301S mutation [Immunogen A] or recombinant 383a.a. human tau (4RON) containing the P301S mutation lacking the N-terminal His tag [Immunogen B] Perform immunization. The immunogen was emulsified in RIBI adjuvant.
Embodiment 2
[0366] Example 2. Epitope Mapping of Antibody 3D6
[0367]A series of overlapping biotinylated peptides spanning the entire 383aa 4RON human tau protein was used to map the murine 3D6 antibody. Additional peptides were used to model potential post-translational modifications of the protein's C- and N-termini.
[0368] Biotinylated peptides were bound to individual wells of streptavidin-coated ELISA plates. Plates were blocked and treated with murine 3D6, followed by incubation with horseradish peroxidase-conjugated anti-mouse antibody. After thorough washing, OPD was applied to the plate and allowed to develop. Read the absorbance of the plate at 450 nm. Absorbance values of wells without primary antibody were used for background subtraction and a threshold of 0.2 absorbance units was set for positive binding. Binding was mapped to sites within the MTBR region.
Embodiment 3
[0369] Example 3. Design of Humanized 3D6 Antibody
[0370] The starting or donor antibody for humanization was the mouse antibody 3D6. The heavy chain variable amino acid sequence of mature m3D6 is provided as SEQ ID NO:7. The light chain variable amino acid sequence of mature m3D6 is provided as SEQ ID NO:11. The heavy chain Kabat / Chothia complex CDR1, CDR2 and CDR3 amino acid sequences are provided as SEQ ID NOs: 8-10, respectively. Light chain Kabat CDR1, CDR2 and CDR3 amino acid sequences are provided as SEQ ID NOs: 12-14, respectively. Always use Kabat numbers.
[0371] The variable kappa (Vk) of 3D6 belongs to mouse Kabat subgroup 2, which corresponds to human Kabat subgroup 2, and the variable heavy chain (Vh) belongs to mouse Kabat subgroup 2c, which corresponds to human Kabat subgroup 2c. 1 Subgroup [Kabat E.A. et al., (1991), Sequences of Proteins of Immunological Interest, Fifth Edition NIH Publication No. 91-3242]. In Vk, the 16-residue Chothia CDR-L1 belongs...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



